Discontinuation report DEMEROL
| Report ID | 98380 |
| Drug Identification Number | 02138018 |
| Brand name | DEMEROL |
| Common or Proper name | Demerol |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MEPERIDINE HYDROCHLORIDE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N02AB |
| ATC description | OPIOIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-05-31 |
| Actual discontinuation date | |
| Remaining supply date | 2020-06-15 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.